Fundació Puigvert performs the first slightly incompatible cross transplant

  • The use of the immunoadsorption technique broadens the possibilities of performing cross transplants.
  • It is estimated that 30% of cases studied as possible living donors are not compatible.

Barcelona, March 18, 2013.-Fundació Puigvert has performed for the first time in Spain a cross kidney transplant in which one of the kidneys was not fully compatible with one of the recipients. The operation was made possible through the immunoadsorption technique, which significantly expands the possibilities of performing these types of transplants, as currently 30% of candidates for possible living donors are not compatible with us.

As Dr. Guirado, Clinical Head of the Kidney Transplant Team at Fundació Puigvert, highlights, this first case opens new avenues in living donor cross kidney transplantation. “This technique benefits not just one recipient, but two, as the cross transplant involves two recipients, neither of whom could receive the organ if the cross operation were not performed,” he explains.

Specifically, the intervention carried out three months ago consisted of a cross kidney transplant between two couples, where there was a mild positive incompatibility that initially made the operation unviable. To achieve compatibility for the kidney, the antibodies from the recipient that caused the incompatibility were removed using an immunoadsorption machine—a mechanism similar to dialysis—allowing the transplant to be performed. This procedure increases compatibility between donor and recipient and even achieves greater compatibility than between some direct relatives.

The reason for incompatibility

The compatibility between donor and recipient largely depends on 12 proteins present in the body, six of which are inherited from the father and six from the mother. This means that the recipient of an organ is considered fully compatible with their donor when both have compatible blood groups and the same 12 proteins. However, it should be noted that the possible combinations of proteins are numerous.

When the body comes into contact with a protein that is not identical to any of its own, it detects it and generates antibodies against that protein. This occurs during a blood transfusion or during pregnancy. The antibodies should not pose any inconvenience to the person who produced them, unless they require a transplant of an organ that has one of the proteins for which they have formed antibodies. At this point, Dr. Guirado points out that antibodies are generated for one or several proteins, which may be present in many people, whether or not they are relatives or have any relation to the person who created the antibodies.   

Therefore, the antibodies that the body has previously formed for a specific protein are the cause of the incompatibility, and if an attempt is made to transplant an organ that has one of these proteins for which the recipient has previously generated antibodies, an acute rejection occurs on the part of the recipient. This is why, until now, cross transplants were only performed when the recipient had not created antibodies against the proteins of their donor prior to the transplant.

More options for living donor kidney transplants

In the intervention with immunoadsorption that was performed on two couples at Fundació Puigvert, there was incompatibility because the recipient of the first couple had pre-formed antibodies against one of the proteins of the donor from the second couple. Thanks to the immunoadsorption machine, these antibodies were eliminated, and both transplants could be performed.

On this first occasion, the procedure was carried out with a case of mild positive incompatibility (with antibodies against one of the 12 proteins), but, as Dr. Guirado highlights, “the idea is to gradually gain ground until we can do it with greater incompatibilities.” Thus, this first case represents a very important step in expanding the options for living donor cross kidney transplantation.

Fundació Puigvert has carried out this intervention with the collaboration of the Organización Nacional de Trasplantes (ONT) and with the Hospital Puerta del Mar de Cádiz, the center from which the second couple involved in the transplant originated.

Fundació Puigvert is a reference entity in Nephrology and Urology. A good example of this is the successes and pioneering interventions developed in these fields:

  • First chain of living donor kidney transplants in Europe, also with the participation of a “good Samaritan” (2011).
  • Second cross kidney transplant from a living donor in Spain (2011).
  • First extraction of a kidney from a living donor with the Da Vinci Robot in Spain (2010).
  • First laparoscopic kidney transplant in the world (2009).
  • First transplant between non-relatives in Spain (2004).